Oxford Asset Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-23,859
| Closed | -$227K | – | 1835 |
|
|
2019
Q1 | $227K | Sell |
23,859
-87,613
| -79% | -$834K | ﹤0.01% | 1478 |
|
|
2018
Q4 | $987K | Buy |
+111,472
| New | +$987K | 0.03% | 874 |
|
|
2018
Q3 | – | Sell |
-85,065
| Closed | -$1.11M | – | 1802 |
|
|
2018
Q2 | $1.11M | Sell |
85,065
-45,873
| -35% | -$598K | 0.02% | 980 |
|
|
2018
Q1 | $2.21M | Sell |
130,938
-27,560
| -17% | -$466K | 0.05% | 516 |
|
|
2017
Q4 | $1.28M | Buy |
+158,498
| New | +$1.28M | 0.03% | 814 |
|
|
2017
Q2 | – | Sell |
-39,926
| Closed | -$297K | – | 1580 |
|
|
2017
Q1 | $297K | Sell |
39,926
-60,256
| -60% | -$448K | 0.01% | 1203 |
|
|
2016
Q4 | $696K | Sell |
100,182
-227,251
| -69% | -$1.58M | 0.02% | 536 |
|
|
2016
Q3 | $2.7M | Sell |
327,433
-81,626
| -20% | -$672K | 0.08% | 337 |
|
|
2016
Q2 | $3.31M | Sell |
409,059
-195,328
| -32% | -$1.58M | 0.11% | 249 |
|
|
2016
Q1 | $3.07M | Buy |
604,387
+326,203
| +117% | +$1.66M | 0.09% | 283 |
|
|
2015
Q4 | $2.16M | Buy |
+278,184
| New | +$2.16M | 0.05% | 384 |
|